Letter to the Editor

  • HOME
  • ARTICLE CATEGORY
  • Letter to the Editor
Letter to the Editor
Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clin Mol Hepatol. 2023;29(1):179-181.   Published online November 22, 2022
View: 402   Download: 24
Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
Clin Mol Hepatol. 2023;29(1):176-178.   Published online November 10, 2022
View: 494   Download: 33
Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
Clin Mol Hepatol. 2023;29(1):173-175.   Published online November 15, 2022
View: 418   Download: 21
Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
Clin Mol Hepatol. 2023;29(1):168.   Published online October 31, 2022
View: 731   Download: 39  Citation: 1
Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
Do Seon Song, U Im Chang, Jin Mo Yang
Clin Mol Hepatol. 2023;29(1):165-167.   Published online October 31, 2022
View: 661   Download: 37  Citation: 1
Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
Seogsong Jeong, Won Kim, Sang Min Park
Clin Mol Hepatol. 2022;28(4):933-934.   Published online September 14, 2022
View: 1018   Download: 43
1704
Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
Li-Yu Lu, Min-You Wu, Yung-Shuo Kao, Cheng-Hsien Hung
Clin Mol Hepatol. 2022;28(4):931-932.   Published online September 5, 2022
View: 1066   Download: 68  Citation: 1
Forms of cholangitis to be considered after SARS-CoV-2 infection
Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
Clin Mol Hepatol. 2022;28(4):929-930.   Published online September 8, 2022
View: 853   Download: 39
1702
Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
Clin Mol Hepatol. 2022;28(4):926-928.   Published online September 5, 2022
View: 937   Download: 43  Citation: 1
1672
Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura
Clin Mol Hepatol. 2022;28(3):575-579.   Published online April 21, 2022
View: 1589   Download: 169  Citation: 1
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):269-272.   Published online February 15, 2022
View: 2233   Download: 225  Citations: 3
Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Jihyun An, Ju Hyun Shim
Clin Mol Hepatol. 2022;28(2):267-268.   Published online January 18, 2022
View: 1480   Download: 38
Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
Yi-Chun Huang, Chih-Wei Chen, James Chun-Chung Wei
Clin Mol Hepatol. 2022;28(2):265-266.   Published online January 4, 2022
View: 4967   Download: 34  Citation: 1
1631
Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura
Clin Mol Hepatol. 2021;27(4):616-619.   Published online September 13, 2021
View: 2631   Download: 176  Citation: 1
Clinical and serological prognostic markers in primary biliary cholangitis
Markus Wilhelmi
Clin Mol Hepatol. 2021;27(2):360-361.   Published online March 23, 2021
View: 2164   Download: 94
A dilemma that probably would never resolve
Ravi Thanage, Shubham Jain, Sanjay Chandnani, Pravin Rathi
Clin Mol Hepatol. 2021;27(1):219-220.   Published online December 3, 2020
View: 2061   Download: 64
Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
Dimitrios Patoulias, Michael Doumas
Clin Mol Hepatol. 2020;26(4):582-583.   Published online September 25, 2020
View: 2267   Download: 63
Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
Jeong Su Park, Soo Han Bae
Clin Mol Hepatol. 2020;26(4):577-578.   Published online September 17, 2020
View: 2348   Download: 57  Citation: 1
Macro-aspartate aminotransferase in a healthy woman
Maria Lorubbio, Agostino Ognibene, Benedetta Salvadori, Alessandra Fanelli, Giacomo Laffi
Clin Mol Hepatol. 2020;26(3):378-381.   Published online June 23, 2020
View: 3159   Download: 111  Citation: 1
How does low-level viremia affect the prognosis of patients with chronic hepatitis B?
Hye Won Lee, Beom Kyung Kim
Clin Mol Hepatol. 2020;26(3):376-377.   Published online June 11, 2020
View: 2993   Download: 104  Citation: 1
Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma
Hwi Young Kim, Jean-François Dufour
Clin Mol Hepatol. 2020;26(2):238-239.   Published online March 18, 2020
View: 2895   Download: 55  Citation: 1
A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B
Yang-Hyun Baek
Clin Mol Hepatol. 2020;26(2):233-235.   Published online April 7, 2020
View: 2896   Download: 94
Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado
Clin Mol Hepatol. 2020;26(2):231-232.   Published online November 4, 2019
View: 3055   Download: 83  Citation: 1
Multimodal sequential treatment for occluded TIPS: Case report and review of literature
Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele
Clin Mol Hepatol. 2020;26(2):227-230.   Published online November 18, 2019
View: 4174   Download: 143

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1339
TOTAL : 1128461
Close layer